Neuronetics, Inc. (STIM): Price and Financial Metrics

Neuronetics, Inc. (STIM)

Today's Latest Price: $8.45 USD

0.06 (-0.71%)

Updated Nov 27 1:00pm

Add STIM to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

STIM Stock Summary

  • Neuronetics Inc's stock had its IPO on June 28, 2018, making it an older stock than merely 6.36% of US equities in our set.
  • As for revenue growth, note that STIM's revenue has grown -16.27% over the past 12 months; that beats the revenue growth of merely 21.7% of US companies in our set.
  • The volatility of Neuronetics Inc's share price is greater than that of 95.12% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to Neuronetics Inc, a group of peers worth examining would be VAPO, PWFL, CFMS, SILK, and OPTN.
  • STIM's SEC filings can be seen here. And to visit Neuronetics Inc's official web site, go to

STIM Stock Price Chart Interactive Chart >

Price chart for STIM

STIM Price/Volume Stats

Current price $8.45 52-week high $8.76
Prev. close $8.51 52-week low $1.25
Day low $8.40 Volume 62,900
Day high $8.75 Avg. volume 489,783
50-day MA $6.08 Dividend yield N/A
200-day MA $3.55 Market Cap 160.34M

Neuronetics, Inc. (STIM) Company Bio

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with psychiatric disorders. It offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment for adult patients with major depressive disorder. The company’s NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed MRI-strength magnetic field, which induces electrical currents designed to stimulate specific areas of the brain associated with mood. Neuronetics, Inc. was founded in 2003 and is based in Malvern, Pennsylvania.

STIM Latest News Stream

Event/Time News Detail
Loading, please wait...

STIM Latest Social Stream

Loading social stream, please wait...

View Full STIM Social Stream

Latest STIM News From Around the Web

Below are the latest news stories about Neuronetics Inc that investors may wish to consider to help them evaluate STIM as an investment opportunity.

Brainsway: Lockdowns Are Hiding Progress In The Business

Brainsway (BWAY) appears deeply undervalued, given its strong unit sales, clear path to profitability, and large addressable market. Although Brainsway is not currently the market leader, they have arguably superior technology to competitors and are focused on obtaining clearance to treat a wider range of conditions. As revenue recovers from...

Richard Durant on Seeking Alpha | August 25, 2020

Neuronetics, Inc. (STIM) CEO Keith Sullivan on Q2 2020 Results - Earnings Call Transcript

Neuronetics, Inc. (STIM) Q2 2020 Earnings Conference Call August 04, 2020 08:30 PM ET Company Participants Mark Klausner - Westwicke Partners, LLC-Managing Partner Keith Sullivan - President & Chief Executive Officer Steve Furlong - Chief Financial Officer Conference Call Participants Margaret Kaczor - William Blair Drew Stafford - Piper Sandler...

SA Transcripts on Seeking Alpha | August 8, 2020

Neuronetics to Report Second Quarter 2020 Financial and Operating Results and Host Conference Call

MALVERN, Pa., July 21, 2020 -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that.

Yahoo | July 21, 2020

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., July 17, 2020 -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on improving the lives of patients who suffer from.

Yahoo | July 17, 2020

Neuronetics (STIM) Looks Good: Stock Adds 11.3% in Session

Neuronetics (STIM) saw a big move last session, as its shares jumped more than 11% on the day, amid huge volumes.

Yahoo | July 17, 2020

Read More 'STIM' Stories Here

STIM Price Returns

1-mo 70.71%
3-mo 43.95%
6-mo 369.44%
1-year 95.60%
3-year N/A
5-year N/A
YTD 88.20%
2019 -76.80%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Continue Researching STIM

Here are a few links from around the web to help you further your research on Neuronetics Inc's stock as an investment opportunity:

Neuronetics Inc (STIM) Stock Price | Nasdaq
Neuronetics Inc (STIM) Stock Quote, History and News - Yahoo Finance
Neuronetics Inc (STIM) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8165 seconds.